Mayne Pharma Group Ltd. logo

Mayne Pharma Group Ltd. (MAYNF)

Market Closed
3 Jul, 20:00
OTC PINK OTC PINK
$
3. 33
0
0%
$
250.64M Market Cap
- P/E Ratio
2.18% Div Yield
0 Volume
-0.43 Eps
$ 3.33
Previous Close
Day Range
3.33 3.33
Year Range
2.42 4.6
Want to track MAYNF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

Mayne Pharma slumps 30% as Cosette threatens to scrap $432 million deal

Shares of Mayne Pharma plunged 30% on Wednesday after U.S.-based Cosette Pharmaceuticals initiated a review of its A$672 million ($432.1 million) acquisition, citing a "material adverse change" in the Australian firm's business and finances.

Reuters | 1 month ago
Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology

Cosette Pharmaceuticals Announces Acquisition of Mayne Pharma, Transforming Company into a Leader in Women's Health and Dermatology

BRIDGEWATER, N.J.--(BUSINESS WIRE)--Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has entered into a definitive agreement to acquire all the outstanding shares of Mayne Pharma Group Limited (ASX: Ticker MYX) (Mayne Pharma) at AUD$7.40/share for a total consideration of approximately USD $430 Million. The Boards of Directors of both companies have approved the transaction and Mayne Pharma's Board of Directors has unanimously recomm.

Businesswire | 4 months ago
Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

Australia's Mayne Pharma sues Indian drugmaker Sun Pharma over patent infringement

Mayne Pharma has filed a patent infringement lawsuit against Indian drugmaker Sun Pharma in a U.S. court, the Australian drugmaker said on Thursday.

Reuters | 11 months ago